financial statements
The full income statement, balance sheet, and cash-flow statement for Biogen Inc. (BIIB), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
| Line item | Trend | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Income Statement | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Revenue | 9.89B YoY+2.2% | 9.68B YoY-1.6% | 9.84B YoY-3.3% | 10.2B YoY-7.4% | 11.0B YoY-18.3% | |
| Cost of revenue | 2.40B YoY+4.1% | 2.31B YoY-8.8% | 2.53B YoY+11.2% | 2.28B YoY+8.0% | 2.11B YoY+16.9% | |
| Research & development | 1.78B YoY-10.2% | 1.98B YoY-19.0% | 2.45B YoY+9.6% | 2.23B YoY-10.8% | 2.50B YoY-37.3% | |
| Selling, general & administrative | 2.43B YoY+1.2% | 2.40B YoY-5.7% | 2.55B YoY+6.1% | 2.40B YoY-10.1% | 2.67B YoY+6.8% | |
| Restructuring | 48.6M YoY+60.9% | 30.2M YoY-86.2% | 219M YoY+66.9% | 131M | 0.00 | |
| Amortization of intangibles | 507M YoY+31.2% | 387M YoY+60.6% | 241M YoY-2.3% | 246M YoY-2.3% | 252M YoY-1.2% | |
| Operating income | — | — | — | — | 2.84B YoY-37.6% | |
| Interest expense | 268M YoY+6.9% | 250M YoY+1.4% | 247M YoY+0.1% | 247M YoY-2.8% | 254M YoY+14.0% | |
| Interest & investment income | 125M YoY+84.9% | 67.6M YoY-75.6% | 277M YoY+209.6% | 89.3M YoY+711.8% | 11.0M YoY-73.8% | |
| Other non-operating income | -24.7M YoY-848.5% | 3.30M YoY+925.0% | -400K YoY-104.0% | 10.1M YoY+80.4% | 5.60M YoY+293.1% | |
| Equity-method income | — | 0.00 | 0.00 YoY-100.0% | 2.60M YoY-92.6% | 34.9M YoY+957.6% | |
| Pre-tax income | 1.56B YoY-18.3% | 1.91B YoY+47.0% | 1.30B YoY-63.9% | 3.59B YoY+105.8% | 1.75B YoY-65.4% | |
| Income tax | 264M YoY-3.7% | 274M YoY+102.4% | 135M YoY-78.6% | 633M YoY+1105.3% | 52.5M YoY-94.7% | |
1.29B YoY-20.8% | 1.63B YoY+40.6% | 1.16B YoY-61.9% | 3.05B YoY+95.8% | 1.56B YoY-61.1% | ||
$8.79 YoY-21.4% | $11.18 YoY+40.3% | $7.97 YoY-61.8% | $20.87 YoY+100.7% | $10.40 YoY-58.1% | ||
| Balance Sheet | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
8.97B YoY+20.3% | 7.46B YoY+8.7% | 6.86B YoY-29.9% | 9.79B YoY+24.6% | 7.86B YoY+14.1% | ||
29.4B YoY+5.0% | 28.0B YoY+4.5% | 26.8B YoY+9.3% | 24.6B YoY+2.8% | 23.9B YoY-3.0% | ||
3.35B YoY-39.4% | 5.53B YoY+61.0% | 3.43B YoY+4.9% | 3.27B YoY-23.9% | 4.30B YoY+14.9% | ||
11.2B YoY-1.3% | 11.3B YoY-5.9% | 12.0B YoY+7.9% | 11.2B YoY-13.6% | 12.9B YoY-7.3% | ||
18.3B YoY+9.2% | 16.7B YoY+13.0% | 14.8B YoY+10.5% | 13.4B YoY+23.0% | 10.9B YoY+1.8% | ||
| Cash Flow | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
2.20B YoY-23.3% | 2.88B YoY+85.9% | 1.55B YoY+11.8% | 1.38B YoY-62.0% | 3.64B YoY-13.9% | ||
-1.37B YoY-71.6% | -799M YoY+80.5% | -4.10B YoY-360.1% | 1.58B YoY+379.7% | -564M YoY+7.4% | ||
-302M YoY+55.8% | -684M YoY-557.8% | 149M YoY+108.5% | -1.75B YoY+16.2% | -2.09B YoY+60.4% | ||
| FX effect on cash | 102M YoY+250.5% | -67.7M YoY-292.9% | 35.1M YoY+163.0% | -55.7M YoY+6.9% | -59.8M YoY-186.7% | |
| Interest paid | 264M YoY+7.6% | 245M YoY-2.7% | 252M YoY-3.9% | 263M YoY-6.5% | 281M YoY+3.0% | |
| Income taxes paid | 864M YoY+143.3% | 355M YoY-52.1% | 741M YoY-20.6% | 933M YoY+276.3% | 248M YoY-72.7% | |
| Valuation Ratios | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Market cap | 25.8B YoY+15.9% | 22.3B YoY-40.6% | 37.5B YoY-6.0% | 39.9B YoY+13.1% | 35.2B YoY-6.5% | |
| P/E | 20.0× YoY+46.2% | 13.7× YoY-46.7% | 25.6× YoY+82.7% | 14.0× YoY-38.1% | 22.6× YoY+140.5% | |
| P/S | 2.6× YoY+13.3% | 2.3× YoY-38.6% | 3.8× YoY-3.3% | 3.9× YoY+20.8% | 3.2× YoY+14.5% | |
| P/B | 1.4× YoY+6.1% | 1.3× YoY-48.5% | 2.6× YoY-17.7% | 3.1× YoY-2.7% | 3.2× YoY-8.1% | |
| P/FCF | 12.6× YoY+53.8% | 8.2× YoY-76.8% | 35.3× YoY+92.6% | 18.3× YoY+75.9% | 10.4× YoY+5.2% | |
| Earnings yield | 5.0% YoY-31.6% | 7.3% YoY+87.7% | 3.9% YoY-45.3% | 7.1% YoY+61.5% | 4.4% YoY-58.4% | |
| FCF yield | 7.9% YoY-35.0% | 12.2% YoY+331.2% | 2.8% YoY-48.1% | 5.5% YoY-43.2% | 9.6% YoY-5.0% | |
| Source filing | 10-K | 10-K | 10-K | 10-K | 10-K |
About this data
Source: BIIB's SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn't file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all BIIB filings on SEC EDGAR → Not investment advice.
